EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Change of Personnel LifeWatch AG: Appointment of Andrew Moore as Chief Financial Officer 02.03.2016 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement. 441743 02.03.2016 ...
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Regulatory Approval LifeWatch AG: FDA clearance for continuous Vital Signs Monitoring Service 09.02.2016 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement. 435611 09.02.2016 ...
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Preliminary Results LifeWatch AG: 2015 revenue growth of 9.8% in core US cardiac monitoring business 29.01.2016 / 19:00 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement. 433293 29.01.2016 ...
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Regulatory Approval LifeWatch AG: FDA clearance for its Mobile Cardiac Telemetry 1-Lead Patch 18.01.2016 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement. 429925 18.01.2016 ...
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Miscellaneous LifeWatch AG: LifeWatch Services, Inc. to suspend Home Sleep Testing Services 17.01.2016 / 19:00 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement. 429923 17.01.2016 ...
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Agreement LifeWatch AG: Agreement with AliveCor, Inc. 11.01.2016 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement. 428069 11.01.2016 ...
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Regulatory Approval LifeWatch AG: CE marking for Mobile Cardiac Telemetry Patch 07.01.2016 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement. 427423 07.01.2016 ...
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Acquisition LifeWatch AG: Acquisition of FlexLife Health Inc., an INR monitoring company co-founded by the Cleveland Clinic 10.11.2015 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this ...
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Change of Personnel LifeWatch AG: Change in the Board of Directors at LifeWatch AG 08.10.2015 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement. 400725 08.10.2015 ...
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Product Launch LifeWatch AG: FDA clearance to run ACT software on the Android(TM) operating system 14.09.2015 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement. 394217 14.09.2015 ...
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Half Year Results LifeWatch AG: LifeWatch AG reports above-market revenue growth of 9.1% and substantial improvement in profitability during first half 2015 20.08.2015 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for ...
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Half Year Results LifeWatch AG: Positive net income expected for the first half of 2015 29.07.2015 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement. 381735 29.07.2015 ...
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Joint Venture LifeWatch AG: LifeWatch AG signs agreement to bring its cardiac moni-toring business to the Turkish market 13.07.2015 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement. ...
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Regulatory Approval LifeWatch AG: LifeWatchTM erhält CE Zulassung für Vital Signs Monitoring 25.06.2015 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement. 371819 25.06.2015 ...
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Legal Matter LifeWatch AG announces ending of Pharma Life litigation 24.06.2015 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement. 371277 24.06.2015 ...
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Regulatory Admission LifeWatch AG: LifeWatchTM Mobile Cardiac Telemetry Patch application filed with the U.S. FDA 13.05.2015 / 07:15 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement. 355777 ...
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): AGM/EGM LifeWatch: Voting results of the Ordinary Annual General Meeting of Shareholders for fiscal year 2014 29.04.2015 / 17:40 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement. 350841 ...
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Final Results LifeWatch AG: 31.03.2015 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement. 339521 31.03.2015 ...
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Change of Personnel LifeWatch AG: Dr. Dominik Aronsky leaves LifeWatch 30.03.2015 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement. 338955 30.03.2015 ...
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Legal Matter LifeWatch AG Files Motion to Dismiss Qui Tam Action 23.03.2015 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement. 335817 23.03.2015 ...
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Final Results LifeWatch achieves turnaround in 2014: Turnover increased by 8.1% with positive Operating Results 18.03.2015 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement. 334249 ...
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Legal Matter LifeWatch AG: Suit Brought Against LifeWatch Services, Inc. by Acacia Subsidiary Dismissed 02.03.2015 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement. 328239 02.03.2015 ...
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Miscellaneous LifeWatch AG: Yacov Geva sells his shares to Swiss investors 04.02.2015 / 11:12 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement. 319305 04.02.2015 ...
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Miscellaneous LifeWatch receives FDA 510(k) clearance for its Vital Signs Patch (VSP) 22.12.2014 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement. 307959 22.12.2014 ...
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Change of Personnel LifeWatch AG: Stefan Vogt named Chief Commercial Officer 08.12.2014 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement. 303131 08.12.2014 ...
LifeWatch AG / Key word(s): Alliance 07.11.2014 21:15 Release of an ad hoc announcement pursuant to Art. 53 KR ...
LifeWatch AG / Key word(s): Agreement 16.10.2014 23:07 Release of an ad hoc announcement pursuant to Art. 53 KR ...
LifeWatch AG / Key word(s): Half Year Results 20.08.2014 07:05 Release of an ad hoc announcement pursuant to Art. 53 KR ...
LifeWatch AG / Key word(s): Change of Personnel 12.08.2014 17:31 Release of an ad hoc announcement pursuant to Art. 53 KR ...
LifeWatch AG / Key word(s): AGM/EGM 28.05.2014 14:59 Release of an ad hoc announcement pursuant to Art. 53 KR ...